BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16969449)

  • 21. Screening and prevention: cervical cancer.
    Weinstein LC; Buchanan EM; Hillson C; Chambers CV
    Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inadequacy of cervical cancer screening among urban recent immigrants: a population-based study of physician and laboratory claims in Toronto, Canada.
    Lofters A; Glazier RH; Agha MM; Creatore MI; Moineddin R
    Prev Med; 2007 Jun; 44(6):536-42. PubMed ID: 17467782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice.
    McCaffery KJ; Irwig L; Chan SF; Macaskill P; Barratt A; Lewicka M; Clarke J; Weisberg E
    Patient Educ Couns; 2008 Dec; 73(3):473-9, 481. PubMed ID: 18757164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV testing for cervical cancer screening in Croatia.
    Grce M; Grahovac B; Rukavina T; Vrdoljak-Mozetic D; Glavas-Obrovac L; Kaliterna V; Zele-Starcević L
    Coll Antropol; 2007 Apr; 31 Suppl 2():67-71. PubMed ID: 17598507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low rates of both asymptomatic chlamydia screening and diagnostic testing of women in US outpatient clinics.
    Hoover K; Tao G; Kent C
    Obstet Gynecol; 2008 Oct; 112(4):891-8. PubMed ID: 18827133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of screening and preventive strategies for cervical cancer in India.
    Patro BK; Nongkynrih B
    Indian J Public Health; 2007; 51(4):216-21. PubMed ID: 18232160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cost effectiveness of human papilloma virus testing in cervical cancer screening: a literature review].
    Mejía A; Salas W
    Biomedica; 2008 Mar; 28(1):160-72. PubMed ID: 18645671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advice for patients. Chlamydia screening: a routine test.
    Moreno MA; Furtner F; Rivara FP
    Arch Pediatr Adolesc Med; 2009 Jun; 163(6):592. PubMed ID: 19487620
    [No Abstract]   [Full Text] [Related]  

  • 32. Informational needs and the experiences of women with abnormal Papanicolaou smears.
    Bertram CC; Magnussen L
    J Am Acad Nurse Pract; 2008 Sep; 20(9):455-62. PubMed ID: 18786022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cervical cancer screening and associated treatment costs in France].
    Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Home sampling and pooling of vaginal samples are effective tools for genetic screening of Chlamydia trachomatis among high school female students in Lithuania.
    Kucinskiene V; Juseviciute V; Valiukeviciene S; Milasauskiene Z; Unemo M; Domeika M
    Scand J Infect Dis; 2008; 40(2):88-93. PubMed ID: 17852902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low prevalence of high-risk HPV in older women not attending organized cytological screening: a pilot study.
    Wikström I; Stenvall H; Wilander E
    Acta Derm Venereol; 2007; 87(6):554-5. PubMed ID: 17989903
    [No Abstract]   [Full Text] [Related]  

  • 38. Personal meaning of human papillomavirus and Pap test results in adolescent and young adult women.
    Kahn JA; Slap GB; Bernstein DI; Tissot AM; Kollar LM; Hillard PA; Rosenthal SL
    Health Psychol; 2007 Mar; 26(2):192-200. PubMed ID: 17385971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can Chlamydia screening in the Emergency Department reach a different section of the target population?
    Stanley L; Ellks R
    Sex Transm Infect; 2012 Nov; 88(7):551. PubMed ID: 22773330
    [No Abstract]   [Full Text] [Related]  

  • 40. Opportunistic screening for chlamydia infection in general practice: can we reach young women?
    Santer M; Warner P; Wyke S; Sutherland S
    J Med Screen; 2000; 7(4):175-6. PubMed ID: 11202582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.